Gastrointestinal tract carcinoid with carcinoid syndrome in 63-year-old diver – a case report
DOI:
https://doi.org/10.12775/JEHS.2023.22.01.011Keywords
Carcinoid, Carcinoid Syndrome, serotonin, Neuroendocrine tumors, carcinoid heart diseaseAbstract
Introduction: Carcinoid is a tumor that originates from neuroendocrine cells.[1] It was primarily named and described in 1907 by Siegfried Oberndorfer to characterize neoplasms located in GIST with a relatively indolent course.[2] Term “carcinoid” is now used to describe. neuroendocrine neoplasms, a subset of rare tumors, mostly sporadic, which are typically located in gastrointestinal tract but they may also appear beyond it (e.g. in thymus or lungs).[2,3] NET’s are highly differentiated and usually hormonally active. Biochemical proof of their presence can consist of a measurement of the released substances – serotonin, bradykinin, histamine, etc. [3]Carcinoid tumors derive from serotonin-producing enterochromaffin cells.[1] They contain high quantities of tryptophane that is transformed later into serotonin. This biogenic amine is responsible for occurrence of so called- carcinoid syndrome. It manifests with hot flushes, diarrhea, tachycardia, vertigo and excessive sweating.[3] The attacks usually last from 0,5 minutes up to half an hour and they can be triggered by food or alcohol consumption, liver palpation or general anesthesia. Due to excessive serotonin production, long lasting carcinoid might lead to right endocardial fibrosis with tricuspid valve and pulmonary valve dysfunction. [4] Description of the case: The following case describes the clinical history, diagnostic process, imaging studies and treatment applied to 63-year-old male professional diver who was admitted to University Hospital of Zielona Góra with a clinical picture that resembled carcinoid syndrome. The final diagnosis- carcinoid originating from the ileum- was settled after performing multiple studies. The patient was referred to the department of Endocrinology and Neuroendocrine Tumors in Silesian University Center in Katowice. He initiated therapy with Somatuline Autogel. The Tumor Board was conducted in order to determine the optimal treatment for the patient.
References
Dias AR, Azevedo BC, Alban LBV, Yagi OK et al. Gastric Neuroendocrine Tumor: Review and Update. Arq Bras Cir Dig. 2017 Apr-Jun;30(2):150-154. doi: 10.1590/0102-6720201700020016
Burkitt MD, Pritchard DM. Review article: Pathogenesis and management of gastric carcinoid tumours. Aliment PharmacolTher. 2006 Nov 1;24(9):1305-20. doi: 10.1111/j.1365-2036.2006.03130.x. PMID: 17059512
Grozinsky-Glasberg S, Davar J, Hofland J, Dobson R, et al. European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease. J Neuroendocrinol. 2022 Jul;34(7):e13146. doi: 10.1111/jne.13146. Epub 2022 May 25.
Ito T, Lee L, Jensen RT. Carcinoid-syndrome: recent advances, current status and controversies. CurrOpin Endocrinol Diabetes Obes. 2018 Feb;25(1):22-35. doi: 10.1097/MED.0000000000000376.
Davar J, Connolly HM, Caplin ME, et al. Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement. J Am Coll Cardiol. 2017;69(10):1288‐1304.
Moerman VM, Dewilde D, Hermans K. Carcinoid heart disease: typical findings on echocardiography and cardiac magnetic resonance. Acta Cardiol. 2012 Apr;67(2):245-8. doi: 10.1080/ac.67.2.2154218. PMID: 22641985.
Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993;87:1188–1196.
Eapen DJ, Clements S Jr, Block P, Sperling L. Metastatic carcinoid disease inducing coronary vasospasm. Tex Heart Inst J. 2012;39(1):76–8 1526-6702
Davar J, Connolly HM, Caplin ME, et al Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement. J. Am. Coll. Cardiol. . 2017. Elsevier USA, 69: 1288–1304
Gangi A, Howe JR. The Landmark Series: Neuroendocrine Tumor Liver Metastases. Ann Surg Oncol. 2020 Sep;27(9):3270-3280. doi: 10.1245/s10434-020-08787-x. Epub 2020 Jul 6.
Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP. Carcinoid syndrome: update on the pathophysiology and treatment. Clinics (Sao Paulo). 2018 Aug 20;73(suppl 1):e490s. doi: 10.6061/clinics/2018/e490s.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Hanna Dominik, Wojciech Pawęska, Barbara Dominik
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 187
Number of citations: 0